2020 -2020 Chief Scientific Officer @ AltruBio Inc. (formerly AbGenomics)
2000 -2019 Founder, CEO and CSO @ AbGenomics
2001 -2019 Chairman Of The Board @ AbGenomics
1997 -2000 Professor and Director @ Graduate Institute of Immunology, College of Medicine, NTU
1993 -1997 Associate Professor and Director @ Graduate Institute of Immunology, College of Medicine, NTU
1991 -1993 Associate Professor @ Graduate Institute of Microbiology, College of Medicine, NTU
Ron Lin Education
Basel Institute for Immunology (Hoffmann-La Roche AG)
Postdoctoral Fellow (Immunology - T cell regulation)
Howard Hughes Medical Institute, Immunobiology at Yale with Professor Charles Janeway
(T cell regulation)
University of Tuebingen and Basel Institute for Immunology
Doctor (Immunology)
University of Tuebingen
Ron Lin Skills
Medicine
Translational Science
Research and Development (R&D)
Clinical Research
Biology
Immunology
Oncology
Supervisory Skills
Biotechnology
Academic Research
Clinical Trials
Teaching
Ron Lin Summary
Ron Lin, based in Houston, TX, US, is currently a Founder and Chief Executive Officer at AgnistaBio Inc.. Ron Lin brings experience from previous roles at Tianti Biotherapeutics, MCure Bioscience, Agnista Therapeutics and AltruBio Inc. (formerly AbGenomics). Ron Lin holds a Postdoctoral Fellow in Immunology - T cell regulation @ Basel Institute for Immunology (Hoffmann-La Roche AG). With a robust skill set that includes Medicine, Translational Science, Research and Development (R&D), Clinical Research, Biology and more. Ron Lin has 1 emails on RocketReach.
Looking for a different Ron Lin?
Find contact details for 700 million professionals.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.